Cognex Corporation

Executive Summary

SELL, Medium conviction. CGNX rates a SELL, Medium conviction for the next 6-12 months. Management is executing well, with raised FY26 guidance and an eight-quarter beat streak, but TTM P/S of 8.48x versus peers at 5.8x leaves little room for the Q4 comparison, automotive weakness, or a slower recovery in Europe. The better long-term opportunity is likely to emerge at a lower entry point than $56.77.

Investment Thesis

The market is valuing Cognex as though the margin repair and AI opportunity will both compound smoothly. That is too generous at $56.77. The shares are down 22.1% from the $72.88 52-week high and 38.1% from the $91.73 five-year high, but they are not washed out: the stock sits just 0.7% below its 200-day average after falling 7.73% over one month. This is a recovery valuation, not a distressed one.

The case depends first on the durability of the earnings recovery. Cognex delivered a real reset in profitability, but the market now needs proof that the recovery extends past the current semiconductor, electronics, packaging, and China strength. Q4 faces a strong 2025 comparison and planned portfolio-exit impacts. More importantly, automotive remains a drag and Europe has not established a clean rebound. These are not peripheral markets when investors are underwriting a premium sales multiple. A 75-basis-point Q3 gross-margin headwind from memory pricing also shows that the business has not become immune to input-cost and mix pressure.

Second, the AI upside is genuine but currently early. Data-center revenue remains only a low-single-digit mix, despite growing above 30% year over year. OneVision has broad initial adoption, but adoption is not yet proof of an earnings stream large enough to justify an enduring premium. The RealSense acquisition could create a more valuable robotic-perception platform, but it also moves Cognex into an integration and commercialization task rather than a finished product cycle.

The rating is not a call that the company lacks quality. The quality score is 64/100, with cash-flow quality at 93, financial health at 84, and profitability at 82. It is a call that valuation appeal is only 34/100, while the risk score of 41/100 is moderate but heavily influenced by valuation at 16.5 out of 25. A lower share price, evidence that Europe and automotive have bottomed, or repeated proof that AI products lift revenue beyond the current end-market cycle would turn the risk-reward more favorable.

Key Metrics

Financial Strength

Cognex has the balance sheet and cash conversion to absorb cyclicality and fund targeted expansion. Low leverage and a strong liquidity profile reduce financial risk, while the improvement from FY2025's 13.8% operating margin to the LTM 21.9% operating margin indicates that cost actions and better mix are reaching reported economics. The key financial question is no longer solvency or cash generation. It is whether current margins can hold through input-cost pressure, portfolio exits, and uneven regional demand.

Competitive Position

Cognex's protection comes from machine-vision application know-how, customer integration into inspection and automation workflows, and a broadening software layer rather than commodity cameras alone. OneVision being generally available with hundreds of customers is the most concrete evidence that AI can deepen the product stack. The moat should be more durable in semiconductor inspection, logistics, and robotic perception than in standard hardware vision, but only if the company converts AI adoption into repeatable deployments before competitors narrow the feature gap.

Management & Guidance

For Q3, management guides revenue of $300M-$320M, adjusted EBITDA margin of 32%-35%, and adjusted EPS of $0.50-$0.54. The FY26 outlook is $1.13B-$1.15B revenue, 29%-31% adjusted EBITDA margin, and $1.64-$1.68 adjusted EPS. Guidance deserves more credibility than usual because Q2 adjusted EBITDA margin beat the prior midpoint by more than 250 bps and the company has beaten Street EPS expectations in eight consecutive reported quarters. The remaining test is whether management can protect the outlook despite the Q4 comparison, portfolio exits, automotive weakness, and the identified Q3 memory-cost pressure.

Segment Analysis

• Semiconductor and electronics (Not disclosed in supplied data): Both were named as leading contributors to Q2's 17% YoY revenue growth; China strength was also driven by these end markets.
• Logistics and packaging (Not disclosed in supplied data): Management raised FY26 outlooks for both; logistics had been identified as a strong-growth market in 2024.
• Automotive (Not disclosed in supplied data): Q2 revenue declined high single digits YoY, extending the strategic weak point highlighted in the 2024 call.
• Geography: China and Europe (Not disclosed in supplied data): China grew 42% YoY in Q2, while Europe fell 15% YoY, or low single digits excluding procurement-routing effects.

Capital Allocation

Balance-sheet discipline is strong: total debt was $0.1B and the current ratio was 3.93 as of 2026-07-05. The supplied deep-dive cash-flow data show $0.1B FCF, with $0.0B capex, buybacks, and dividends in the reported period, indicating that current capital deployment is oriented toward preserving flexibility rather than returning cash. The announced RealSense acquisition is strategically more important than financial engineering because it extends Cognex into robotic perception, but its purchase price and return thresholds were not supplied.

Management Execution & Track Record

Management has materially improved operating delivery since the 2024 Q3 call. At that time, Q3 adjusted EBITDA margin was 17.6%, management guided Q4 to 14%-17%, and automotive was described as exceptionally weak; the supplied record does not include the subsequent Q4 actual, so that specific guide cannot be fully audited. What can be audited is the subsequent cadence: Cognex beat Street EPS estimates in all eight reported quarters from 2024-10-30 through 2026-08-05, including beats of 33.3%, 23.1%, 36.9%, and 6.2% in the last six reported quarters. The current team has turned that operating control into a 30.4% Q2 adjusted EBITDA margin and FY26 margin guidance of 29%-31%, while completing OneVision general availability and targeting $35M of annualized cost reductions by end-2026. The strategy has evolved from defending share amid Moritex dilution and China pricing pressure to monetizing AI vision and robotics perception. Credibility is high on costs and quarterly delivery, but less proven on the duration of the auto and Europe recovery.

Positioning & Flows

Institutional ownership is concentrated, with the top three institutions holding 88.3% and insiders holding only 0.5%, which can amplify moves when large holders change views. Reported short interest is 4.31%, or 7,220,863 shares, with 3.5 days-to-cover, enough for an earnings-driven squeeze but not evidence of a crowded short. Options gamma is reported positive, which can dampen near-term volatility; zero-gamma and call/put-wall levels were not available in the supplied data.

Bull Case

• Q2 revenue grew 17% YoY to a record quarterly level, led by semiconductor, electronics, packaging, and logistics, and management raised its FY26 outlook for each of those markets.
• China revenue rose 42% YoY in Q2, driven by semiconductor and electronics demand, demonstrating that Cognex can grow despite prior pricing pressure in that market.
• Management expects approximately $35M of annualized net cost reductions by the end of 2026, supporting the FY26 adjusted EBITDA margin range of 29%-31%.
• LTM free-cash-flow conversion reached 114%, while LTM debt/EBITDA was only 0.26x as of 2026-07-05, giving Cognex capacity to fund product expansion without balance-sheet strain.

Bear Case

• Automotive revenue fell high single digits YoY in Q2, and management still faces a difficult auto demand environment after prior EV project delays and cancellations.
• Europe revenue declined 15% YoY in Q2, or low single digits excluding procurement-routing effects, leaving a material regional recovery unproven.
• Memory pricing creates an estimated 75 bps Q3 gross-margin headwind; management expects pricing actions to offset it only in 2027.
• The stock is only 22.1% below its 52-week high of $72.88 but carries an 8.48x TTM P/S multiple, leaving valuation exposed if the FY26 growth recovery fades.

Valuation & Price Target

Engine price target $51.74 (-8.9% vs current), Medium confidence.

• P/E Multiple: $62.48 (28% weight)
• P/S Multiple: $35.28 (20% weight)
• Quality-adjusted: $63.13 (20% weight)
• DCF: $12.53 (5% weight)

The SELL is a deliberate step below the quant baseline HOLD. The engine's $51.74 target implies -8.9% from $56.77 and supports caution, while the valuation blend is unusually dispersed: $62.48 on P/E, $35.28 on P/S, $63.13 quality-adjusted, and only $12.53 on DCF. Strong guidance, balance-sheet quality, and earnings execution argue against an aggressive short, but the lower P/S and DCF outputs better capture the risk that a cyclical recovery is already priced in. Sell-side consensus is Buy, with 3 buy, 5 hold, and 0 sell ratings across 8 firms, but it is low-signal context and does not offset the valuation asymmetry.

Risk Assessment

Risk score 41/100 (Moderate). The principal risk to the SELL is that the FY26 guide of $1.64-$1.68 adjusted EPS proves conservative and AI-led semiconductor, China, and data-center demand sustains margin expansion above the 29%-31% adjusted EBITDA target.

The Bottom Line

CGNX is rated SELL, Medium conviction for 6-12 months. The company is executing better than the share-price setup implies, but the stock still prices a clean continuation of recovery while key regions and automotive remain unresolved. November 4 can drive a near-term upside move if Q3 again beats and FY26 rises, which is why the near-term stance is HOLD rather than SELL aggressively. The rating would change with a lower valuation, sustained evidence that Europe and automotive have turned, or proof that AI products create revenue growth beyond the current semiconductor and China cycle.